LPBI Group would like to thank all our readers who have helped our Journal to Hit the 1 Million Viewer Mark!
Newtown, MA -- (SBWIRE) -- 06/20/2016 -- Leaders in Pharmaceutical Business Intelligence (LBPI Group), launched in April 2012 as an Open Access Online Scientific Journal (http://pharmaceuticalintelligence.com), has reached over 1 million unique site visits, with approximately 30,000 monthly views, +2,115 followers, and 300 sites linking into the journal, including ncbi.nlm.nih.gov, Nature.com, commons.wikipedia.org, dx.doi.org, NEJM, personalizedmedicine.partners.org, cancer.gov, medscape.com, masspec.scripps.edu, and sciencedirect.com.
Leaders in Pharmaceutical Business Intelligence Group is a scientific, medical and business multi-expert authoring platform in several domains: life sciences, pharmaceutical, healthcare & medical industries. The venture operates as an online scientific intellectual exchange at its website http://pharmaceuticalintelligence.com for curation and reporting on innovations in biomedical and biological sciences, healthcare economics, pharmacology, pharmaceutical research & medicine. The Open Access Online Scientific Journal currently contains 4,716 annotated & curated articles in over +480 categories of research in Biotech, Life Sciences and Medicine.
About The LBPI Group 3D Printing ADD R&D
The LBPI Group venture publishes a BioMedical Series of e-Books available on mobile platforms (current & future titles at http://pharmaceuticalintelligence.com/biomed-e-books). It also represents a dozen Biotechnology and Medical Devices startups in Private Equity Funding and an IP Development Group, DrugDiscovery@LPBI Group, and Medical 3D Printing.
The venture's expertise in Real-Time Scientific Conferences Coverage, using social media and creating electronic conference proceedings posted on the Internet, has included the following events as well as others: Harvard's 10th, 11th, 12th Personalized Medicine Conferences in 2015 & 2016, CHI Discovery On Target 2016, MassBio 2015 & 2016, MassBioAnnual Meeting 2014, BioIT World, April 30, 2014, Koch Institute for Integrative Cancer Research @MIT – Summer Symposium 2014: RNA Biology, Cancer and Therapeutic Implications, June 13, 2014, Gabbay Award Lectures in Biotechnology and Medicine – Hosted by Rosenstiel Basic Medical Sciences Research Center, Brandeis University, October 27, 2014, 10th Annual Personalized Medicine Conference at the Harvard Medical School, November 12-13, 2014, and two Biotech Investment Conferences in 2014, one in NYC and one in Basel by Sachs Associates of London.